Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.

Authors:
Aaron M Shapiro Carolyn S Jack Yves Lapierre Nathalie Arbour Amit Bar-Or Jack P Antel

Arch Neurol 2006 Sep;63(9):1296-9

Neuroimmunology Unit and Multiple Sclerosis Clinic, Montreal Neurological Institute, 3801 University Street, Montreal, Quebec.

Background: A proportion of patients with multiple sclerosis (MS) receiving systemic interferon beta therapy will develop serum neutralizing antibodies (NAbs) that can reduce the activity of the drug. Interferon-beta (IFN-beta) is produced by glial cells within the central nervous system. Although systemic interferon beta does not access the central nervous system, titers of serum NAbs may be sufficient that some will access the central nervous system.

Objective: To address whether serum samples that contain high titers of NAbs could inhibit glial cell production of chemokines and cytokines that are regulated by endogenous IFN-beta.

Design: We used an in vitro assay involving toll-like receptor 3 ligand (polyinosinic-polycytidylic acid) signaling to assess the effect of serum samples containing high titers of NAbs (1800-20 000 U) on production of the chemokine CXCL10 and the cytokine interleukin 6 by human astrocytes.

Results: Serum samples positive for NAbs significantly inhibited polyinosinic-polycytidylic acid-induced CXCL10 and IL-6 production by astrocytes.

Conclusion: High-titer NAbs to interferon beta may block endogenous IFN-beta function and alter the chemokine/cytokine microenvironment within the central nervous system, thereby modulating the profile and course of the local inflammatory response.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.63.9.1296DOI Listing
September 2006

Publication Analysis

Top Keywords

central nervous
20
nervous system
16
serum samples
12
interferon beta
12
multiple sclerosis
8
titers nabs
8
high titers
8
samples high
8
systemic interferon
8
access central
8
nabs
6
serum
6
central
5
nervous
5
1800-20 000
4
assay involving
4
vitro assay
4
involving toll-like
4
receptor ligand
4
signaling assess
4

Similar Publications

Hereditary Myelopathies.

Authors:
Melissa A Walker

Semin Neurol 2021 Mar 4. Epub 2021 Mar 4.

Division of Child Neurology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Hereditary myelopathies are an important and likely underappreciated component of neurogenetic disease. While previously distinctions have been made by age of onset, the growing power and availability of high-quality neuroimaging and next-generation sequencing are increasingly expanding classical phenotypes and diminishing the utility of age-based classifications. Increasingly, cases of "atypical" disease presentations are challenging past assumptions regarding the age of onset and survival in many disorders and identifying allelic syndromes in others. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.

Authors:
William E Rosenfeld Arkady Nisman Louis Ferrari

Epilepsy Res 2021 Feb 18;172:106592. Epub 2021 Feb 18.

SK Life Science, Inc., Paramus, NJ, USA.

Background: In an 18-week, double-blind, placebo-controlled study (YKP3089C017; NCT01866111), cenobamate was effective for the treatment of focal-onset seizures. This post-hoc analysis examined the effects of baseline clinical features on the efficacy of adjunctive cenobamate during the study.

Methods: Adults with uncontrolled focal seizures despite treatment with 1-3 antiepileptic drugs/antiseizure medications (AEDs/ASMs) were randomized 1:1:1:1 to placebo or cenobamate 100, 200, or 400 mg once daily. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

A 3-armed multicenter randomized controlled trial: Placental Transfusion in Very Preterm Infants (PT-VPI).

Authors:
Guang Yue Yan Wu Fangping Zhao Chunyi Zhang Dan Zhao Jingjie Lu Qiaoyan Fang Xia Li Yijun Wei Miao Qian Lin Yi Shan Zheng Ruihua Ba Liqian Luo Jiping Luo Shuai Zhao Jiangyi Lu Xia Huang Guoqing Wei Yufeng Xi Shuqiang Gao Xuhong Hu Rong Ju

Contemp Clin Trials 2021 Mar 1:106337. Epub 2021 Mar 1.

Neonatal Department, Chengdu Women's and Children's Central Hospital, School of Medicine, School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China. Electronic address:

Preterm infants constitute an important proportion of neonatal deaths and various complications, and very preterm infants (VPI) are more likely to develop severe complications, such as intraventricular hemorrhage (IVH), anemia, and sepsis. It has been confirmed that placental transfusion can supplement blood volume in infants and reduce preterm-associated complications, which is further conducive to the development of the nervous system and a better long-term prognosis. Based on these advantages, placental transfusion has been widely used in VPI. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Extracellular mitochondria in the cerebrospinal fluid (CSF): potential types and key roles in central nervous system (CNS) physiology and pathogenesis.

Authors:
Andrés Caicedo Kevin Zambrano Serena Sanon Antonio W D Gavilanes

Mitochondrion 2021 Mar 1. Epub 2021 Mar 1.

Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, 17-12-841, Quito, Ecuador; School for Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, The Netherlands.

The cerebrospinal fluid (CSF) has an important role in the transport of nutrients and signaling molecules to the central nervous and immune systems through its circulation along the brain and spinal cord tissues. The mitochondrial activity in the central nervous system (CNS) is essential in processes such as neuroplasticity, neural differentiation and production of neurotransmitters. Interestingly, extracellular and active mitochondria have been detected in the CSF where they act as a biomarker for the outcome of pathologies such as subarachnoid hemorrhage and delayed cerebral ischemia. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Presynaptic voltage-gated calcium channels in the auditory brainstem.

Authors:
Samuel M Young Priyadharishini Veeraraghavan

Mol Cell Neurosci 2021 Mar 1:103609. Epub 2021 Mar 1.

Department of Anatomy and Cell Biology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.

Sound information encoding within the initial synapses in the auditory brainstem requires reliable and precise synaptic transmission in response to rapid and large fluctuations in action potential (AP) firing rates. The magnitude and location of Ca entry through voltage-gated Ca channels (Ca) in the presynaptic terminal are key determinants in triggering AP-mediated release. In the mammalian central nervous system (CNS), the Ca2. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap